Sign In
Buy CYTK
$80.01
+0.84 (+1.06%)
At Close: Jun 23, 2026
Cytokinetics to Present at the 44th Annual J.P. Morgan Healthcare Conference
04:00pm, Monday, 05'th Jan 2026
SOUTH SAN FRANCISCO, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I.
Ethic Inc. Purchases Shares of 9,522 Cytokinetics, Incorporated $CYTK
05:06am, Monday, 05'th Jan 2026
Ethic Inc. acquired a new position in Cytokinetics, Incorporated (NASDAQ: CYTK) in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The
PHILADELPHIA, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ: CYTK). The investi
Cytokinetics (NASDAQ:CYTK) EVP Sells $112,953.96 in Stock
04:52am, Friday, 02'nd Jan 2026
Cytokinetics, Incorporated (NASDAQ: CYTK - Get Free Report) EVP Andrew Callos sold 1,809 shares of the company's stock in a transaction dated Monday, December 29th. The shares were sold at an average
PHILADELPHIA, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ: CYTK). The investi
Wendell Wierenga Sells 20,000 Shares of Cytokinetics (NASDAQ:CYTK) Stock
04:44am, Thursday, 25'th Dec 2025
Cytokinetics, Incorporated (NASDAQ: CYTK - Get Free Report) Director Wendell Wierenga sold 20,000 shares of the firm's stock in a transaction that occurred on Monday, December 22nd. The stock was sold
Squarepoint Ops LLC Has $608,000 Holdings in Cytokinetics, Incorporated $CYTK
05:10am, Wednesday, 24'th Dec 2025
Squarepoint Ops LLC trimmed its position in Cytokinetics, Incorporated (NASDAQ: CYTK) by 82.3% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities
Traders Purchase Large Volume of Cytokinetics Call Options (NASDAQ:CYTK)
01:14am, Tuesday, 23'rd Dec 2025
Cytokinetics, Incorporated (NASDAQ: CYTK - Get Free Report) was the target of some unusual options trading activity on Monday. Traders acquired 5,619 call options on the stock. This represents an incr
Cytokinetics: Small Label Differences With Big Commercial Stakes
05:33pm, Monday, 22'nd Dec 2025
Cytokinetics, Incorporated remains a Buy following FDA approval of MYQORZO (aficamten) for obstructive hypertrophic cardiomyopathy (oHCM). ORZO's label offers subtle practical advantages over CAMZYOS,
Cytokinetics Wins FDA Nod For Heart Drug Myqorzo
11:23am, Monday, 22'nd Dec 2025
On Friday, the U.S. Food and Drug Administration (FDA) approved Cytokinetics Incorporated's (NASDAQ: CYTK) Myqorzo (aficamten) for symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to improve
Cytokinetics Wins FDA Approval for Cardiovascular Drug, Stock up
10:31am, Monday, 22'nd Dec 2025
CYTK enters a new era as FDA approval of Myqorzo transforms it into a commercial biotech, opening a long-term growth runway in cardiology.
Cytokinetics, Incorporated (CYTK) Discusses FDA Approval of MYQORZO for Symptomatic Obstructive Hypertrophic Cardiomyopathy Transcript
PHILADELPHIA, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ: CYTK). The investi
Market Today: Oracle-TikTok JV, Tesla Pay Reinstated, Nike Sinks
05:35pm, Friday, 19'th Dec 2025
Guru Stock PicksVanguard Health Care Fund has made the following transactions:Reduce in ARGX by 14.38%Sold out in PACSAdd in CLDX by 3.64%New position in PTGXCI
US FDA approves Cytokinetics' heart disease drug
04:08pm, Friday, 19'th Dec 2025
The U.S. Food and Drug Administration has approved Cytokinetics' drug to treat a rare heart condition, the company said on Friday.
